Form 4: XWELL Inc. Director Gaelle Wizenberg Acquires Stock Options

Director Gaelle Wizenberg of XWELL, Inc. was granted stock options for 22,019 shares of common stock.

Summary

• Gaelle Wizenberg, a director at XWELL, Inc., has acquired stock options for 22,019 shares of the company's common stock.
• The options were granted on November 15, 2024, at an exercise price of $1.6548 per share.
• These options vest 100% on the first anniversary of the grant date, provided Ms. Wizenberg continues to provide services to the company.
• The options expire on November 15, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages continued service to the company.

Industry Context

Stock option grants are a common practice for incentivizing directors and aligning their interests with the long-term success of the company.

Comparison to Industry Standards

• Stock option grants to directors are a standard practice across many industries, including technology and healthcare, to align their interests with shareholders.
• Vesting periods of one year are also common, encouraging long-term commitment from the director.
• The exercise price of $1.6548 is specific to XWELL and would need to be compared to the current market price of the stock to assess its value.

Stakeholder Impact

• The stock option grant could be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

stock options, insider trading, beneficial ownership, XWELL, director, equity